Selected research
Industry Growth & Trends
Global OTC Cough and Cold and Allergy Medicine Industry Growth and Trends Forecast to 2032
Market perspective
The global OTC Cough and Cold and Allergy Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of OTC Cough and Cold and Allergy Medicine include Allergen, AstraZaneca, Bristol-Myers Squib, Prestige Brands Holdings, Procter and Gamble, Reckitt Benckiser Group, Sanofi-Aventis, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global OTC Cough and Cold and Allergy Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The OTC Cough and Cold and Allergy Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Cough and Cold and Allergy Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Cough and Cold and Allergy Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global OTC Cough and Cold and Allergy Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
OTC Cough and Cold and Allergy Medicine Market by Company
Allergen
AstraZaneca
Bristol-Myers Squib
Prestige Brands Holdings
Procter and Gamble
Reckitt Benckiser Group
Sanofi-Aventis
GlaxoSmithKline
Pfizer
Merck and Co.
Novartis
Johnson and Johnson
Sun Pharmaceutical Industries
OTC Cough and Cold and Allergy Medicine Segment by Type
Antibiotics
Antihistamine
Expectorants
Bronchodialators
Others
OTC Cough and Cold and Allergy Medicine Segment by Application
Online
Offline
OTC Cough and Cold and Allergy Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cough and Cold and Allergy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Cough and Cold and Allergy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cough and Cold and Allergy Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Cough and Cold and Allergy Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of OTC Cough and Cold and Allergy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibiotics
- Antihistamine
- Expectorants
- Bronchodialators
- Others
Applications
- Online
- Offline
Companies covered
- Allergen
- AstraZaneca
- Bristol-Myers Squib
- Prestige Brands Holdings
- Procter and Gamble
- Reckitt Benckiser Group
- Sanofi-Aventis
- GlaxoSmithKline
- Pfizer
- Merck and Co.
- Novartis
- Johnson and Johnson
- Sun Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global OTC Cough and Cold and Allergy Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global OTC Cough and Cold and Allergy Medicine Sales Estimates and Forecasts (2021-2032)
- 1.3 OTC Cough and Cold and Allergy Medicine Market by Type
- 1.3.1 Antibiotics
- 1.3.2 Antihistamine
- 1.3.3 Expectorants
- 1.3.4 Bronchodialators
- 1.3.5 Others
- 1.4 Global OTC Cough and Cold and Allergy Medicine Market Size by Type
- 1.4.1 Global OTC Cough and Cold and Allergy Medicine Market Size Overview by Type (2021-2032)
- 1.4.2 Global OTC Cough and Cold and Allergy Medicine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global OTC Cough and Cold and Allergy Medicine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America OTC Cough and Cold and Allergy Medicine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe OTC Cough and Cold and Allergy Medicine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America OTC Cough and Cold and Allergy Medicine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 OTC Cough and Cold and Allergy Medicine Industry Trends
- 2.2 OTC Cough and Cold and Allergy Medicine Industry Drivers
- 2.3 OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges
- 2.4 OTC Cough and Cold and Allergy Medicine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by OTC Cough and Cold and Allergy Medicine Revenue (2021-2026)
- 3.2 Global Top Players by OTC Cough and Cold and Allergy Medicine Sales (2021-2026)
- 3.3 Global Top Players by OTC Cough and Cold and Allergy Medicine Price (2021-2026)
- 3.4 Global OTC Cough and Cold and Allergy Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global OTC Cough and Cold and Allergy Medicine Major Company Production Sites & Headquarters
- 3.6 Global OTC Cough and Cold and Allergy Medicine Company, Product Type & Application
- 3.7 Global OTC Cough and Cold and Allergy Medicine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global OTC Cough and Cold and Allergy Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 OTC Cough and Cold and Allergy Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 OTC Cough and Cold and Allergy Medicine Tier 1, Tier 2, and Tier 3
4 OTC Cough and Cold and Allergy Medicine Regional Status and Outlook
- 4.1 Global OTC Cough and Cold and Allergy Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global OTC Cough and Cold and Allergy Medicine Historic Market Size by Region
- 4.2.1 Global OTC Cough and Cold and Allergy Medicine Sales in Volume by Region (2021-2026)
- 4.2.2 Global OTC Cough and Cold and Allergy Medicine Sales in Value by Region (2021-2026)
- 4.2.3 Global OTC Cough and Cold and Allergy Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global OTC Cough and Cold and Allergy Medicine Forecasted Market Size by Region
- 4.3.1 Global OTC Cough and Cold and Allergy Medicine Sales in Volume by Region (2027-2032)
- 4.3.2 Global OTC Cough and Cold and Allergy Medicine Sales in Value by Region (2027-2032)
- 4.3.3 Global OTC Cough and Cold and Allergy Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 OTC Cough and Cold and Allergy Medicine by Application
- 5.1 OTC Cough and Cold and Allergy Medicine Market by Application
- 5.1.1 Online
- 5.1.2 Offline
- 5.2 Global OTC Cough and Cold and Allergy Medicine Market Size by Application
- 5.2.1 Global OTC Cough and Cold and Allergy Medicine Market Size Overview by Application (2021-2032)
- 5.2.2 Global OTC Cough and Cold and Allergy Medicine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global OTC Cough and Cold and Allergy Medicine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America OTC Cough and Cold and Allergy Medicine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe OTC Cough and Cold and Allergy Medicine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America OTC Cough and Cold and Allergy Medicine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Allergen
- 6.1.1 Allergen Company Information
- 6.1.2 Allergen Business Overview
- 6.1.3 Allergen OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.1.5 Allergen Recent Developments
- 6.2 AstraZaneca
- 6.2.1 AstraZaneca Company Information
- 6.2.2 AstraZaneca Business Overview
- 6.2.3 AstraZaneca OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.2.5 AstraZaneca Recent Developments
- 6.3 Bristol-Myers Squib
- 6.3.1 Bristol-Myers Squib Company Information
- 6.3.2 Bristol-Myers Squib Business Overview
- 6.3.3 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.3.5 Bristol-Myers Squib Recent Developments
- 6.4 Prestige Brands Holdings
- 6.4.1 Prestige Brands Holdings Company Information
- 6.4.2 Prestige Brands Holdings Business Overview
- 6.4.3 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.4.5 Prestige Brands Holdings Recent Developments
- 6.5 Procter and Gamble
- 6.5.1 Procter and Gamble Company Information
- 6.5.2 Procter and Gamble Business Overview
- 6.5.3 Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.5.5 Procter and Gamble Recent Developments
- 6.6 Reckitt Benckiser Group
- 6.6.1 Reckitt Benckiser Group Company Information
- 6.6.2 Reckitt Benckiser Group Business Overview
- 6.6.3 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.6.5 Reckitt Benckiser Group Recent Developments
- 6.7 Sanofi-Aventis
- 6.7.1 Sanofi-Aventis Company Information
- 6.7.2 Sanofi-Aventis Business Overview
- 6.7.3 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.7.5 Sanofi-Aventis Recent Developments
- 6.8 GlaxoSmithKline
- 6.8.1 GlaxoSmithKline Company Information
- 6.8.2 GlaxoSmithKline Business Overview
- 6.8.3 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.8.5 GlaxoSmithKline Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 Merck and Co.
- 6.10.1 Merck and Co. Company Information
- 6.10.2 Merck and Co. Business Overview
- 6.10.3 Merck and Co. OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.10.5 Merck and Co. Recent Developments
- 6.11 Novartis
- 6.11.1 Novartis Company Information
- 6.11.2 Novartis Business Overview
- 6.11.3 Novartis OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.11.5 Novartis Recent Developments
- 6.12 Johnson and Johnson
- 6.12.1 Johnson and Johnson Company Information
- 6.12.2 Johnson and Johnson Business Overview
- 6.12.3 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.12.5 Johnson and Johnson Recent Developments
- 6.13 Sun Pharmaceutical Industries
- 6.13.1 Sun Pharmaceutical Industries Company Information
- 6.13.2 Sun Pharmaceutical Industries Business Overview
- 6.13.3 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio
- 6.13.5 Sun Pharmaceutical Industries Recent Developments
7 North America by Country
- 7.1 North America OTC Cough and Cold and Allergy Medicine Sales by Country
- 7.1.1 North America OTC Cough and Cold and Allergy Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
- 7.1.3 North America OTC Cough and Cold and Allergy Medicine Sales Forecast by Country (2027-2032)
- 7.2 North America OTC Cough and Cold and Allergy Medicine Market Size by Country
- 7.2.1 North America OTC Cough and Cold and Allergy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America OTC Cough and Cold and Allergy Medicine Market Size by Country (2021-2026)
- 7.2.3 North America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe OTC Cough and Cold and Allergy Medicine Sales by Country
- 8.1.1 Europe OTC Cough and Cold and Allergy Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
- 8.1.3 Europe OTC Cough and Cold and Allergy Medicine Sales Forecast by Country (2027-2032)
- 8.2 Europe OTC Cough and Cold and Allergy Medicine Market Size by Country
- 8.2.1 Europe OTC Cough and Cold and Allergy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe OTC Cough and Cold and Allergy Medicine Market Size by Country (2021-2026)
- 8.2.3 Europe OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales by Country
- 9.1.1 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific OTC Cough and Cold and Allergy Medicine Market Size by Country
- 9.2.1 Asia-Pacific OTC Cough and Cold and Allergy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific OTC Cough and Cold and Allergy Medicine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America OTC Cough and Cold and Allergy Medicine Sales by Country
- 10.1.1 South America OTC Cough and Cold and Allergy Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
- 10.1.3 South America OTC Cough and Cold and Allergy Medicine Sales Forecast by Country (2027-2032)
- 10.2 South America OTC Cough and Cold and Allergy Medicine Market Size by Country
- 10.2.1 South America OTC Cough and Cold and Allergy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America OTC Cough and Cold and Allergy Medicine Market Size by Country (2021-2026)
- 10.2.3 South America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country
- 11.1.1 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Size by Country
- 11.2.1 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 OTC Cough and Cold and Allergy Medicine Value Chain Analysis
- 12.1.1 OTC Cough and Cold and Allergy Medicine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 OTC Cough and Cold and Allergy Medicine Production Mode & Process
- 12.2 OTC Cough and Cold and Allergy Medicine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 OTC Cough and Cold and Allergy Medicine Distributors
- 12.2.3 OTC Cough and Cold and Allergy Medicine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst